: : E l n o . We conducted a study to evaluate field worker exposure to azinphosmethyl during peach harvest. Monitoring was conducted using dislodgeable foliar residues, dermal dosimeters, urinary metabolites, butyrylcholinesterase, and acetylcholinesterase. Harvester exposures have historically been difficult to measure because dermal exposure monitoring provides only an exposure index, and although it is typically the primary exposure route, it may not reflect the important sources of exposure. The traditional method of using dermal dosimeters to measure potential dermal exposure, whether whole-body clothing or gauze pads, gives data that are inaccurate predictors of absorbed dose in humans (1, 2) .
Biological monitoring provides a means of indicating absorption or effect of the compound under study. Azinphosmethyl has been a suitable candidate for assessment using biological monitoring because of background information on dermal exposure and dermal absorption in humans and animals under laboratory conditions (3) (4) (5) . Franklin and co-workers reported a strong linear correlation between urinary alkylphosphate levels and both dermal doses of azinphosmethyl in rats and amount of pesticide sprayed for orchard applicators (4, 5) . The assessment of azinphosmethyl exposure via biological monitoring has been successful in previous studies (6) (7) (8) .
Materials and Methods
Orchard workers were monitored for exposure to azinphosmethyl residues while picking peaches for processing in Sutter County, California. Sampling consisted of dermal dosimeters, 24-hr urine collections, and blood draws for cholinesterase effects. The crew was Spanish speaking, and an interpreter explained the procedures and solicited the workers' voluntary cooperation. Workers agreeing to participate gave written informed consent. The pickers were male and the sorters were male and female. All participants performed their work in the usual manner, and additional instructions were not given beyond explaining the study procedures. Some workers included with the sorters performed additional tasks including fruit hauling and supervising. Height, weight, and age were obtained for each study volunteer. Since detailed questionnaires were not administered, additional information regarding personal habits, diet, etc., was not available. The sorters were considered to have had minimal exposure to azinphosmethyl and were used as a control group for the pickers. The sorters lived in the area and had no exposure to organophosphates prior to the start of the harvest season. The sorters go through the fruit contained in the bins in the field, removing culls or fruit that is too green. The orchards were sampled for dislodgeable foliar residues (DFR) using the methods of Gunther et al. (9) . Samples were taken from 10 (11, 12) . This kit uses an Ellman-like spectrophotometric method adapted for field studies. Procedural modifications were 1) automatic micropipettes were used to add the 120 p1 buffer and 160 p1 distilled water, and 2) a micropipette was used to transfer the dissolved ChE reagent to the spectrophotometer cuvette. Results were automatically temperature adjusted and electronically displayed for hemoglobinadjusted AChE (AChE divided by hemoglobin = IU/g hemoglobin).
Urine Monitoring Each worker was provided with 1-1 polyethylene urine collection bottles as needed each day. Workers were instructed to collect all urine for a 24-hr period that began with the start of the work day and ended after the next morning's void. At the end of every 24 hr the volumes were recorded and a 100-ml aliquot was stored in a 250-ml polyethylene bottle. Multivariate analyses were used for analyzing cross-sectional comparisons of ChE levels between exposed harvesters and minimally exposed sorters, while simultaneously considering longitudinal changes in ChE over time in both groups. These analyses were conducted using the SAS procedure PROC MIXED (14) . PROC MIXED as used here is analogous to the SAS PROC GLM multivariate analyses using the REPEATED feature, although
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Results
DFR values for azinphosmethyl ranged from 0.82 to 1.72 pg/cm2 over the 3-week study period. Azinphosmethyl levels did not vary significantly during the study, with means of 1.34 ± 0.04 pg/cm2 (n = 19 ), 1.18 ± The mean daily dermal exposure for the 3 monitoring days was 32 ± 1.6 mg (n = 41) and ranged from 17.9 to 60.5 mg per person per day. Mean results were similar for each day with levels of 31.2 ± 1.3 mg (n = 15); 35.6 ± 3.2 mg (n = 13); and 31.1 ± 3.2 mg (n = 13) for August 19, 20, and 21, respectively. The long-sleeved undershirts, the hands, and the face/neck wipes accounted for 82%, 16%, and 2% of the total body exposure, respectively. Oxon levels were detected on all sampling media and ranged from 0.6 to 3.7 mg on the shirts, 0.1 to 0.4 mg on the hands, and 0.002 to 0.05 mg for the face/neck wipes. The oxon residues accounted for 6% of the dermal exposure. Figures 1 and 2 show the results for AChE and BChE for both exposed (harvesters) and controls (sorters), for both labs. Preexposure values were within the range of laboratory norms. For AChE, harvesters have lower values than sorters for the two post-exposure blood draws, and harvesters, but not sorters, show a decrease over time after exposure begins. BChE shows little difference between exposure groups. Both groups show a downward shift in comparison to their baseline values. The shift in BChE values suggests the occurrence of laboratory drift (15) .
Cholinesterase Monitoring
Means for BChE and AChE for harvesters and sorters are given in Table 2 When regression lines for AChE were fit separately for exposed and control groups over time (each lab separately), the exposed group showed a significantly negative (downward) slope over time (-0.041 mol\min\ml per day, p = 0.003, at lab 2 and -32.87 IU per day, p = 0.0004, at lab 1). Although expressed in different units, these downward slopes were similar in magnitude. In contrast, the control group showed a flat (lab 1) or upward (lab 2) slope over time. For both laboratories, the slopes of the regression lines for exposed and controls differed significantly.
Intercepts at baseline did not differ for either laboratory. Table 4 presents correlation coefficients and significance levels between AChE methods by date for the exposed group. All correlations were highly significant for all test days.
Multivariate analyses of the AChE data showed no effect of age, weight, height, or sex. A cell mean model (ANOVA) showed a significant difference between the average of the two post-exposure AChE means, with exposed lower than controls, for both laboratories (p = 0.0007 for lab 1 and p = 0.0002 for lab 2).
Urinary Monitoring
The results of the analyses for the presence of DMP and DMTP are reported in Table  5 . Values for DMDTP are not reported because it was not detected in 90% of the samples. Mean creatinine values were 1.4 g/l with 90% of the 24-hr urine collection having volumes greater than 700 ml. Both Dermal exposure on day 1 correlated with total metabolites (DMP + DMTP) collected the following morning (r = 0.58, p = 0.04); total metabolites collected after 48 hr were less well correlated (r = 0.47, p = 0.08). Other comparisons of dermal exposure to urinary metabolites had associated p-values >0.10. There was no difference in urinary metabolite levels between those pickers monitored for dermal exposure and pickers providing only 24-hour voids.
To assess the correlation between urinary phosphates and ChE among the exposed group, we averaged the five urinary phosphate levels (August 20, 21, 22, 23, and September 6), and then correlated these means with the average post-exposure (August 25 and September 5) AChE and BChE (after subtraction off the baseline value). The results ( Discussion DFR levels were twice those found during the 2 previous years at this location in 1989 (7) (0.59 pg/cm ) and 1990 (8) (0.46 pg/cm2),although application rates were unchanged over the 3 years. This is similar to the observations of other researchers (16, 17) , where DFR levels varied from 0.43 to 2.2 pig/cm2 14 days after application at the same locale over 2 consecutive years. DFR samples were not taken at the time of application, but the half-life for azinphosmethyl at this locale was previously calculated to be 32 ± 7 days (8). Knaak et al. (18) calculated a safe level for azinphosmethyl on foliage of 1.6 pig/cm2 using dermal dose-response curves for cholinesterase inhibition, developed from animal models, and field exposure data. Knaak's method took into account the higher toxicity levels of the oxon residues, which were not detected in this study. DFR levels remained unchanged over the study period, and any trend reflecting changes in dermal exposure or urinary metabolite levels could not be evaluated in its relationship to foliage residues.
Dermal exposure measurements of 32 mg were similarly twice the levels measured the previous 2 years at 15.5 mg in 1989 and 13 mg in 1990 (7, 8) . The contribution of the dermal exposure measured from the long-sleeved shirts was greater than in the 2 previous years, (82% versus 66% and 57% in 1989-90) but was similar to the exposure distribution measured at three other locations (8) . The mean cumulative dermal exposure for the 3 days of dermal monitoring was 98.4 mg per person. The cumulative urinary equivalents (the ratio of the molecular weight of azinphosmethyl to the molecular weight of the various metabolites) was 37.8 mg for the 4 consecutive days that correspond to the dermal monitoring. An indirect estimate of 28% dermal absorption was calculated by dividing the urinary equivalents by the sum of dermal exposure and urinary equivalents. This estimate is similar to previous estimates for dermal absorption ranging from 17% to 35% azinphosmethyl (8) and is within the range of 16-42%, depending on regional variation in absorption, found in laboratory studies (4, 19) . Feldman and Maibach (3) showed urinary metabolite excretion for azinphosmethyl to be 5.5, 5, 3, 1.4, and 1%, respectively, for days 1-5 after a single topical application. Our study showed an increase in urinary phosphates levels for consecutive exposure days due to the additive effects of previous exposure days. This additive effect may account for the poor correlations that were seen between dermal exposure and urinary metabolites after the first exposure day. Dermal exposure is comparatively easier to monitor and in some situations one might prefer to use dermal exposure as a predictor of absorbed dose in humans. Dialkylphosphate results for September 5-6 were lower than expected because harvesters had been exposed for 3 consecutive days to DFR levels similar to those of August 26. This decline could be related to differences in growth habit that were observed between tree varieties. The trees harvested earlier in the season had denser foliage, and the later variety grew more vaselike, with an open canopy, allowing the worker to contact less foliage during picking.
Urinary phosphates are an indicator of exposure. Because exposure conditions are likely to be relatively uniform for all workers on a given day, urinary phosphate levels on a given day may vary principally due to different work practices by different workers, although unique absorption and excretion biology may also account for some interindividual variability. Urinary phosphates were measured on 5 separate days, and pairwise correlations for exposed workers between these different days were consistently highly positive and highly significant, probably indicating that some workers consistently engaged in work practices which led to higher exposures than other workers. When we averaged all five urine measurements taken during the entire exposure period and compared them to the average of the two post-exposure cholinesterase measurements (after subtracting the baseline ChE), we found a significant inverse correlation at both labs for AChE, but not for BChE. This finding is in accord with our findings for cholinesterase, which indicate that pesticide exposure among these workers resulted in some measurable inhibition of AChE, but no BChE inhibition. In a previous study (7) where monitoring was conducted under similar circumstances, the correlation with urinary phosphates was poor for both BChE and AChE values, but DFR values were half those in this study. Richards et al. (17) studied workers thinning peaches and correlated dialkylphosphate metabolites with percent decline in AChE (r = -0.581 and -0.598 for DMP and DMTP, respectively) where azinphos-2 methyl DFR levels were 2.2 pg/cm , results similar to our findings.
Our findings for AChE indicated that exposed workers experienced a 10-20% decrease over the 3-week exposure period, while the minimally exposed controls did not. BChE was not affected. These findings are consistent with the literature showing an AChE but not BChE effect of azinphosmethyl, as is typical for methylated organophosphates (17) . Biologically, it is plausible that workers exposed at a relatively constant dose would exhibit constantly decreasing AChE levels over time (as opposed to an initial inhibition, which remains constant over the exposure period). However, this depends on a complicated interaction between the strength of the organophosphate cholinesterase bond, the regeneration rate of red cells, and the level of dose.
The Test-Mate OP Kit was easy to use in the field and the workers preferred the finger prick to the drawing of a venous blood sample. McConnell et al. (20) found that the kit performed well in the field with interindividual variability of 7.4% for a nonexposed group for hemoglobin-adjusted AChE. In this study the coefficient of variation was approximately 10% for the control group hemoglobin-adjusted values. Although there were positive correlations with the other two laboratories and the kit, the lack of a "gold standard" for cholinesterase prevents any conclusions regarding the relative validity of the kit and laboratory for cholinesterase measurements.
